Jeffrey S Glenn - Net Worth and Insider Trading
Jeffrey S Glenn Net Worth
The estimated net worth of Jeffrey S Glenn is at least $96,016 dollars as of 2024-11-13. Jeffrey S Glenn is the Director of Eiger BioPharmaceuticals Inc and owns about 11,296 shares of Eiger BioPharmaceuticals Inc (EIGRQ) stock worth over $96,016. Details can be seen in Jeffrey S Glenn's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeffrey S Glenn has not made any transactions after 2022-12-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jeffrey S Glenn
Jeffrey S Glenn Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeffrey S Glenn owns 1 companies in total, including Eiger BioPharmaceuticals Inc (EIGRQ) .
Click here to see the complete history of Jeffrey S Glenn’s form 4 insider trades.
Insider Ownership Summary of Jeffrey S Glenn
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EIGRQ | Eiger BioPharmaceuticals Inc | 2022-12-22 | director |
Jeffrey S Glenn Latest Holdings Summary
Jeffrey S Glenn currently owns a total of 1 stock. Jeffrey S Glenn owns 11,296 shares of Eiger BioPharmaceuticals Inc (EIGRQ) as of December 22, 2022, with a value of $96,016.
Latest Holdings of Jeffrey S Glenn
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EIGRQ | Eiger BioPharmaceuticals Inc | 2022-12-22 | 11,296 | 8.50 | 96,016 |
Holding Weightings of Jeffrey S Glenn
Jeffrey S Glenn Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeffrey S Glenn has made a total of 3 transactions in Eiger BioPharmaceuticals Inc (EIGRQ) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Eiger BioPharmaceuticals Inc is the acquisition of 3,333 shares on December 22, 2022, which cost Jeffrey S Glenn around $128,000.
Insider Trading History of Jeffrey S Glenn
- 1
Jeffrey S Glenn Trading Performance
GuruFocus tracks the stock performance after each of Jeffrey S Glenn's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeffrey S Glenn is 19.76%. GuruFocus also compares Jeffrey S Glenn's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeffrey S Glenn within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jeffrey S Glenn's insider trading performs compared to the benchmark.
Performance of Jeffrey S Glenn
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 14.9 | | | | | |
| Relative Return to S&P 500(%) | 9.83 | | | | | |
Jeffrey S Glenn Ownership Network
Ownership Network List of Jeffrey S Glenn
Ownership Network Relation of Jeffrey S Glenn
Jeffrey S Glenn Owned Company Details
What does Eiger BioPharmaceuticals Inc do?
Who are the key executives at Eiger BioPharmaceuticals Inc?
Jeffrey S Glenn is the director of Eiger BioPharmaceuticals Inc. Other key executives at Eiger BioPharmaceuticals Inc include 10 percent owner Richard A Kayne , 10 percent owner Leen Kawas , and Chief Business Officer Ingrid Choong .
Eiger BioPharmaceuticals Inc (EIGRQ) Insider Trades Summary
Over the past 18 months, Jeffrey S Glenn made no insider transaction in Eiger BioPharmaceuticals Inc (EIGRQ). Other recent insider transactions involving Eiger BioPharmaceuticals Inc (EIGRQ) include a net purchase of 278,239 shares made by Richard A Kayne , and a net purchase of 24,332 shares made by Leen Kawas .
In summary, during the past 3 months, insiders sold 0 shares of Eiger BioPharmaceuticals Inc (EIGRQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eiger BioPharmaceuticals Inc (EIGRQ) were sold and 10,086 shares were bought by its insiders, resulting in a net purchase of 10,086 shares.
Eiger BioPharmaceuticals Inc (EIGRQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eiger BioPharmaceuticals Inc Insider Transactions
Jeffrey S Glenn Mailing Address
Above is the net worth, insider trading, and ownership report for Jeffrey S Glenn. You might contact Jeffrey S Glenn via mailing address: 350 Cambridge Avenue, Suite 350, Palo Alto Ca 94306.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
